Effective Treatments for Hot Flashes Identified
Understanding Menopause and Hot Flashes
A recent review published in the *International Journal of Obstetrics and Gynecology* highlights the most effective treatments for alleviating hot flashes. Menopause is a gradual transition marked by the cessation of ovarian function and the absence of menstrual periods for 12 consecutive months. This period results in a decline of hormones, including estrogen, progesterone, and testosterone, which can disrupt the body’s ability to regulate heat. Consequently, women may experience sudden increases in blood flow to the chest, neck, and face, leading to symptoms such as excessive sweating, chills, heart palpitations, and the sensation of extreme heat, commonly referred to as hot flashes.
The Role of the Vasomotor Center
The vasomotor center in the brain regulates this process, managing blood pressure-related changes in menopausal women. The symptoms that arise are classified as vasomotor symptoms, primarily known as hot flashes. Treatment for these symptoms typically involves medications that influence hormone levels. Researchers in the United Kingdom aimed to determine which treatments are the most effective.
Network Meta-Analysis Methodology
Study Overview
The systematic review in the *International Journal of Obstetrics and Gynecology* identified effective treatments for relieving vasomotor symptoms in menopausal women who have not undergone hysterectomy. Researchers conducted a review of randomized controlled trials involving 8,326 women across three meta-analysis networks in the UK. Network meta-analysis is recognized as the optimal method for comparing multiple treatments for a single condition, particularly when these treatments have been evaluated in varied trials.
Comparative Analysis of Treatment Classes
The analysis focused on both pharmacological and non-pharmacological treatments aimed at alleviating vasomotor symptoms, minimizing adverse events, and reducing discontinuation rates. Participants were categorized into three groups: women with a uterus, women without a uterus, and women with a history of or at risk for breast cancer. The investigation compared 16 treatment classes, including a placebo, transdermal estradiol and progestogen, oral estradiol and progestogen, isoflavones, black cohosh, serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors.
Findings on Treatment Efficacy
Most Effective Treatment Identified
The results indicated that transdermal estradiol and progestogen emerged as the most effective treatment for alleviating hot flashes. While isoflavones and black cohosh were more effective than a placebo, they did not demonstrate significant superiority over transdermal estradiol and progestogen. Conversely, selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors proved to be the least effective in symptom relief, although they had higher rates of discontinuation compared to the placebo, which may have influenced the findings.
Conclusion on Treatment Options
Although oral estrogen plus progestogen showed some effectiveness, transdermal estradiol combined with progestogen was more successful in reducing hot flash frequency among women who had not undergone hysterectomy. Research of this nature is critical, as understanding treatment effectiveness enhances clinical decision-making regarding the best options for relieving symptoms in menopausal women.
Study Acknowledgment
This article was authored by Viola Lanier PhD, MScG Sarri, H Pedder, S Dias, Y Guo, and MA Lumsden in the study titled “Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause,” published on May 11, 2017.